Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher N Scanlan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Mass Spectrometry : JMS|September 13, 2008
Application of negative ion MS/MS to the identification of N-glycans released from carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1)David J Harvey, Kavitha Baruah, Christopher N Scanlan
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2008
Making autoantibodies safeChristopher N Scanlan, Dennis R Burton, Raymond A Dwek
Nature|April 27, 2007
Exploiting the defensive sugars of HIV-1 for drug and vaccine designChristopher N Scanlan, John Offer, Nicole Zitzmann, et al.
Journal of Molecular Biology|February 19, 2013
Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domainXiaojie Yu, Snezana Vasiljevic, Daniel A Mitchell, et al.
Science (New York, N.Y.)|January 4, 2014
Emerging principles for the therapeutic exploitation of glycosylationMartin Dalziel, Max Crispin, Christopher N Scanlan, et al.
Journal of the American Society for Mass Spectrometry|September 21, 2012
MALDI-MS/MS with traveling wave ion mobility for the structural analysis of N-linked glycansDavid J Harvey, Charlotte A Scarff, Max Crispin, et al.
Journal of Molecular Biology|April 10, 2012
Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactionsKavitha Baruah, Thomas A Bowden, Benjamin A Krishna, et al.
AIDS (London, England)|October 4, 2008
Antigenic mimicry of the HIV envelope by AIDS-associated pathogensD Cameron Dunlop, Alexander Ulrich, Ben J Appelmelk, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigensKatie J Doores, Camille Bonomelli, David J Harvey, et al.
Plos One|August 23, 2011
The glycan shield of HIV is predominantly oligomannose independently of production system or viral cladeCamille Bonomelli, Katie J Doores, D Cameron Dunlop, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Mass Spectrometry : JMS|September 13, 2008
Application of negative ion MS/MS to the identification of N-glycans released from carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1)David J Harvey, Kavitha Baruah, Christopher N Scanlan
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2008
Making autoantibodies safeChristopher N Scanlan, Dennis R Burton, Raymond A Dwek
Nature|April 27, 2007
Exploiting the defensive sugars of HIV-1 for drug and vaccine designChristopher N Scanlan, John Offer, Nicole Zitzmann, et al.
Journal of Molecular Biology|February 19, 2013
Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domainXiaojie Yu, Snezana Vasiljevic, Daniel A Mitchell, et al.
Science (New York, N.Y.)|January 4, 2014
Emerging principles for the therapeutic exploitation of glycosylationMartin Dalziel, Max Crispin, Christopher N Scanlan, et al.
Journal of the American Society for Mass Spectrometry|September 21, 2012
MALDI-MS/MS with traveling wave ion mobility for the structural analysis of N-linked glycansDavid J Harvey, Charlotte A Scarff, Max Crispin, et al.
Journal of Molecular Biology|April 10, 2012
Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactionsKavitha Baruah, Thomas A Bowden, Benjamin A Krishna, et al.
AIDS (London, England)|October 4, 2008
Antigenic mimicry of the HIV envelope by AIDS-associated pathogensD Cameron Dunlop, Alexander Ulrich, Ben J Appelmelk, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigensKatie J Doores, Camille Bonomelli, David J Harvey, et al.
Plos One|August 23, 2011
The glycan shield of HIV is predominantly oligomannose independently of production system or viral cladeCamille Bonomelli, Katie J Doores, D Cameron Dunlop, et al.
Pageof 3